You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 12, December 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

A 5-year study of cryosurgery in the treatment of liver tumors

T. S. Ravikumar, R. Kane, B. Cady, R. Jenkins, M. Clouse and G. Steele Jr
Department of Surgery, Yale University School of Medicine, New Haven, CT 06510.

This report summarizes our 5-year experience with cryosurgery for in situ ablation of liver tumors. The liver was exposed with laparotomy, and the tumors were subjected to two freeze-thaw cycles using liquid nitrogen delivered by insulated probes; cryoablation was monitored with intraoperative ultrasonography. Tumor markers and computed tomography evaluated tumor response during long-term follow-up. From 1985 to 1990, 32 patients (19 men and 13 women) were entered into this study. The histologic characteristics of the tumors were as follows: colorectal, 24 patients; hepatoma, three patients; neuroendocrine, two patients; and others, three patients. After a follow-up period of 5 to 60 months (median follow-up, 24 months), nine patients (28%) remained disease free, 11 patients (34%) were alive with disease, and 12 patients (38%) died. The patterns of failure included liver and extrahepatic disease in 54% of cases, liver disease only in 32% of cases, and extrahepatic disease only in 14% of cases. In patients with "liver only" failure, recurrence at the treatment site occurred in three patients (9%). This study establishes the long-term effectiveness of cryosurgery in the treatment of primary and metastatic liver tumors.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Biochemical and Hematologic Alterations Following Percutaneous Cryoablation of Liver Tumors: Experience in 48 Procedures
Nair et al.
Radiology 2008;248:303-311.
ABSTRACT | FULL TEXT  

Knowing When Not to Operate on Cancer: The Essence of Surgical Oncology and the Challenge for the Mentor
Weese
Ann. Surg. Oncol. 2006;13:450-452.
FULL TEXT  

Radiofrequency Ablation of Colorectal Liver Metastases: Where Are We Really Going?
Poston
JCO 2005;23:1342-1344.
FULL TEXT  

Intraoperative Ultrasonography: History, Current State of the Art, and Future Directions
Kane
J Ultrasound Med 2004;23:1407-1420.
FULL TEXT  

Radiofrequency Ablation of Hepatic Malignancies: Inexpensive and Minimally Invasive but Should It Replace Resection?
Bilchik and Faries
Ann. Surg. Oncol. 2003;10:1002-1004.
FULL TEXT  

A Comparison of Percutaneous Cryosurgery and Percutaneous Radiofrequency for Unresectable Hepatic Malignancies
Adam et al.
Arch Surg 2002;137:1332-1339.
ABSTRACT | FULL TEXT  

Efficacy of Fluorine-18-Deoxyglucose Positron Emission Tomography in Detecting Tumor Recurrence After Local Ablative Therapy for Liver Metastases: A Prospective Study
Langenhoff et al.
JCO 2002;20:4453-4458.
ABSTRACT | FULL TEXT  

Radiofrequency Ablation of the Porcine Liver With Complete Hepatic Vascular Occlusion
Chang et al.
Ann. Surg. Oncol. 2002;9:594-598.
ABSTRACT | FULL TEXT  

Hand-Assisted Laparoscopic Liver Surgery
Antonetti et al.
Arch Surg 2002;137:407-412.
ABSTRACT | FULL TEXT  

Hepatic Radiofrequency Ablation
Iannitti et al.
Arch Surg 2002;137:422-427.
ABSTRACT | FULL TEXT  

Systemic Irinotecan and Regional Floxuridine After Hepatic Cytoreduction in 185 Patients With Unresectable Colorectal Cancer Metastases
Litvak et al.
Ann. Surg. Oncol. 2002;9:148-155.
ABSTRACT | FULL TEXT  

Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation
Primrose
Gut 2002;50:1-5.
ABSTRACT | FULL TEXT  

Safety and Efficacy of Radiofrequency Thermal Ablation in Advanced Liver Tumors
Bowles et al.
Arch Surg 2001;136:864-869.
ABSTRACT | FULL TEXT  

Phase I Study of Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic Irinotecan for Unresectable Hepatic Metastases From Colorectal Cancer
Kemeny et al.
JCO 2001;19:2687-2695.
ABSTRACT | FULL TEXT  

Colorectal Hepatic Metastases: Resection, Local Ablation, and Hepatic Artery Infusion Pump Are Associated With Prolonged Survival
Heslin et al.
Arch Surg 2001;136:318-323.
ABSTRACT | FULL TEXT  

Radiofrequency Ablation of Unresectable Hepatic Malignancies: Lessons Learned
Bilchik et al.
The Oncologist 2001;6:24-33.
ABSTRACT | FULL TEXT  

Local Tumor Recurrence Following Hepatic Cryoablation: Radiologic-histopathologic Correlation in a Rabbit Model
Kuszyk et al.
Radiology 2000;217:477-486.
ABSTRACT | FULL TEXT  

Hepatic Cryoablation-Induced Acute Lung Injury: Pulmonary Hemodynamic and Permeability Effects in a Sheep Model
Chapman et al.
Arch Surg 2000;135:667-673.
ABSTRACT | FULL TEXT  

CT-monitored Percutaneous Cryoablation in a Pig Liver Model: Pilot Study
Lee et al.
Radiology 1999;211:687-692.
ABSTRACT | FULL TEXT  

Surgical Treatment and Other Regional Treatments for Colorectal Cancer Liver Metastases
Yoon and Tanabe
The Oncologist 1999;4:197-208.
ABSTRACT | FULL TEXT  

Laparoscopic Cryoablation of Hepatic Metastases
Iannitti et al.
Arch Surg 1998;133:1011-1015.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.